Detalhe da pesquisa
1.
SBNO2 is a critical mediator of STAT3-driven hematological malignancies.
Blood
; 141(15): 1831-1845, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36630607
2.
A STAT5B-CD9 axis determines self-renewal in hematopoietic and leukemic stem cells.
Blood
; 138(23): 2347-2359, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320169
3.
Oncogenic TYK2 P760L kinase is effectively targeted by combinatorial TYK2, mTOR and CDK4/6 kinase blockade.
Haematologica
; 108(4): 993-1005, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35021603
4.
CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia.
Blood
; 136(4): 387-400, 2020 07 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32344427
5.
Inducible deletion of CDK4 and CDK6 - deciphering CDK4/6 inhibitor effects in the hematopoietic system.
Haematologica
; 106(10): 2624-2632, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32855282
6.
Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose.
Retrovirology
; 11: 8, 2014 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24444350
7.
Dual-layer surface coating of PLGA-based nanoparticles provides slow-release drug delivery to achieve metronomic therapy in a paclitaxel-resistant murine ovarian cancer model.
Biomacromolecules
; 15(11): 4187-94, 2014 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25251833
8.
A robust approach for the generation of functional hematopoietic progenitor cell lines to model leukemic transformation.
Blood Adv
; 5(1): 39-53, 2021 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33570624
9.
Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets.
Leukemia
; 35(7): 1964-1975, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33168949
10.
Selective inhibition of STAT3 signaling using monobodies targeting the coiled-coil and N-terminal domains.
Nat Commun
; 11(1): 4115, 2020 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32807795